Pfizer seeks booster approval for all adults

Pfizer and BioNTech has requested approval for all adults in the U.S. to receive their COVID-19 vaccine boosters.

On Tuesday, the company presented recent data to the U.S. Food and Drug Administration showing the shot would help prevent disease across ages.

President Joe Biden announced plans over the summer to roll out booster shots for all adults in September.

The FDA has authorized Pfizer, Moderna and Johnson & Johnson boosters for the most vulnerable populations: the elderly, immunocompromised, and frontline workers.

However, it's held back wider approval for all people aged 16 or over due to a lack of evidence of its benefit for younger people.

Pfizer presented data from a clinical study published last month, which showed that a booster dose was over 95 percent effective against COVID-19, compared to a vaccinated group without a third shot.

Many U.S. health officials agree that boosters also prevent hospitalizations and deaths and can even slow mild infections.

Moderna is likely to file a similar request with the FDA to approve its boosters for all adults, according to CNBC.

Roughly 25 million Americans had received a booster as of this week.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting